Till now, a number of NF-κB inhibitors have been demonstrated to induce thyroid cancer cell apoptosis, for instance, SN50, DHMEQ, bortezomib and Bay 11-7082. This evidence concerns the gene NFKB1 and thyroid gland carcinoma.